CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects...

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial...

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech...

Cyberattacks in Hospitals

Cyberattacks in Hospitals

How AI Can Enhance the Prediction of Immunotherapy

How AI Can Enhance the Prediction of...

How Technology is Reshaping Immunotherapy

How Technology is Reshaping...

Life Sciences 4.0: Revamping Life Science Manufacturing

By Life Sciences Review | Monday, June 15, 2020
Tweet

Realizing the promises of life sciences 4.0 will be the market differentiator for businesses competing in today’s environment.


FREMONT, CA: There is increasing interest among the leaders and decision-makers in the life sciences industry around the world. Life sciences manufacturers face an ever-present need to remain competitive in a marketplace where product portfolios are diversifying, innovative companies challenging the status-quo, supply chain partners becoming more integrated and patients more involved in care decisions. Realizing the promises of life sciences 4.0 will be the market differentiator for businesses competing in this environment. Taking a strategic approach to determining an organization’s maturity in digital manufacturing operations can be vital in moving forward. Read on to know more.


Current trends and the increasingly accelerating rate of change in the industry, make it vital for life sciences organizations to insert practical innovation into their manufacturing processes and leverage the tremendous volume of data generated within their value chains. For this, companies must utilize advanced technologies to digitize end-to-end processes or risk competitive disadvantage in a world of collaboration within and across industry verticals.


 


Life sciences companies with in-house manufacturing maintain their manufacturing operations on outdated platforms, with a reluctance to change to more advanced technology due to perceived product quality, safety hurdles and costs associated with revalidating a working, licensed manufacturing process. Life sciences manufacturing leaders know that safely and efficiently manufacturing drugs or medical devices relies on collecting and storing the required data and leveraging it in ways previously not possible. Stakeholders can utilize Industry 4.0 capabilities to sense, predict and automate functions on the shop floor.


With data and connected devices, manufacturers can enhance overall equipment efficiency and productivity by proactively sensing equipment failure based on run-time data and invoking a predictive maintenance activity. This can contribute to improving production processes by reducing planned downtime and breakdowns.  In conclusion, the life science industry is mitigating risk with the life sciences 4.0 revolution. Also, with this revolution, the new products, processes and services will be cheaper, faster, safer and of higher quality than their predecessors.


See also: Top Smart Labs Consulting/Services Companies


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of ADCs

Must-Know Biotechnology Trends in 2021

Must-Know Biotechnology Trends in 2021

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development
Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/life-sciences-40-revamping-life-science-manufacturing-nwid-89.html